newsfilter
← Latest News
GlobeNewswire·

Organovo On Track to Establish Human 3D Disease Model in Inflammatory Bowel Disease in 2022

SAN DIEGO, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO), today provided a business overview and progress update, and announced it is on track to establish its first models of inflammatory bowel disease in 2022 using its 3D bi